2nd Annual BIO India International Partnering Conference

2nd Annual BIO India International Partnering Conference
September 21-22, 2011
Hyderabad, India

This exclusive forum will bring together biotechnology and pharmaceutical companies from North America, Europe and Asia to meet and explore business opportunities with India’s emerging biotech sector.

Keynote Speakers Announced

• G.V. Prasad, Vice Chairman and CEO, Dr. Reddy's Laboratories
• Glenn Saldanha, Managing Director & CEO, Glenmark Pharmaceuticals

Apollo and ACPE Offer Post-Graduate Diploma in Advanced Physician Leadership

Apollo and ACPE Offer Post-Graduate Diploma in Advanced Physician Leadership

The programme consists of 14 courses totaling 150 credit hours, covering subjects relating to professional management of hospital and healthcare organisations

In order to meet the growing demand for formally trained physician executives in India, Apollo Hospitals Group, Asia’s largest corporate healthcare organisation, in association with the American College of Physician Executives (ACPE) of USA will offer Asia’s first Post-Graduate Diploma in Advanced Physician Leadership (PGD-APL) programme.

ACPE (www.acpe.org) has been in operation in the US and Canada since 1975. It originated at the Medical School of the University of Wisconsin, Madison and has demonstrated expertise in adapting the distance education model.

First Annual BIO India International Partnering Conference

First Annual BIO India International Partnering Conference

An International Partnering Conference

September 21 - 22, 2010

Hyderabad, India

Organized by: Biotechnology Industry Organization (BIO)
Local Host: Association of Biotechnology Led Enterprises (ABLE)

India is the world’s most rapidly-developing biotech center

India’s biotech sector...

* is growing at a rate of 20%, with total revenues set to reach $5 billion in 2010.
* includes over 280 companies, six of whom generate revenues of over $22 million.

During the past 18 months, the world’s top biotech and pharmaceutical companies—including Abbott, Amylin, AstraZeneca, GSK, Optimer, and Pfizer—have concluded major acquisitions and licensing deals in India. These industry leaders are partnering with Indian companies to develop therapeutics and diagnostics; conduct discovery research, contract research, and clinical trials.

Learn more here: http://bioindia.bio.org